Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway
- PMID: 21775467
- PMCID: PMC3187504
- DOI: 10.1128/JVI.00671-11
Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway
Abstract
Public health measures successfully contained outbreaks of the severe acute respiratory syndrome coronavirus (SARS-CoV) infection. However, the precursor of the SARS-CoV remains in its natural bat reservoir, and reemergence of a human-adapted SARS-like coronavirus remains a plausible public health concern. Vaccination is a major strategy for containing resurgence of SARS in humans, and a number of vaccine candidates have been tested in experimental animal models. We previously reported that antibody elicited by a SARS-CoV vaccine candidate based on recombinant full-length Spike-protein trimers potentiated infection of human B cell lines despite eliciting in vivo a neutralizing and protective immune response in rodents. These observations prompted us to investigate the mechanisms underlying antibody-dependent enhancement (ADE) of SARS-CoV infection in vitro. We demonstrate here that anti-Spike immune serum, while inhibiting viral entry in a permissive cell line, potentiated infection of immune cells by SARS-CoV Spike-pseudotyped lentiviral particles, as well as replication-competent SARS coronavirus. Antibody-mediated infection was dependent on Fcγ receptor II but did not use the endosomal/lysosomal pathway utilized by angiotensin I converting enzyme 2 (ACE2), the accepted receptor for SARS-CoV. This suggests that ADE of SARS-CoV utilizes a novel cell entry mechanism into immune cells. Different SARS vaccine candidates elicit sera that differ in their capacity to induce ADE in immune cells despite their comparable potency to neutralize infection in ACE2-bearing cells. Our results suggest a novel mechanism by which SARS-CoV can enter target cells and illustrate the potential pitfalls associated with immunization against it. These findings should prompt further investigations into SARS pathogenesis.
Figures
![Fig. 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3187504/bin/zjv9990950170001.gif)
![Fig. 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3187504/bin/zjv9990950170002.gif)
![Fig. 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3187504/bin/zjv9990950170003.gif)
![Fig. 4.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3187504/bin/zjv9990950170004.gif)
![Fig. 5.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3187504/bin/zjv9990950170005.gif)
![Fig. 6.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3187504/bin/zjv9990950170006.gif)
![Fig. 7.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3187504/bin/zjv9990950170007.gif)
![Fig. 8.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3187504/bin/zjv9990950170008.gif)
Similar articles
-
SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement.Hong Kong Med J. 2012 Feb;18 Suppl 2:31-6. Hong Kong Med J. 2012. PMID: 22311359
-
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.Biochem Biophys Res Commun. 2014 Aug 22;451(2):208-14. doi: 10.1016/j.bbrc.2014.07.090. Epub 2014 Jul 26. Biochem Biophys Res Commun. 2014. PMID: 25073113 Free PMC article.
-
Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro.Vaccine. 2007 Jan 8;25(4):729-40. doi: 10.1016/j.vaccine.2006.08.011. Epub 2006 Aug 22. Vaccine. 2007. PMID: 17049691 Free PMC article.
-
The role of IgG Fc receptors in antibody-dependent enhancement.Nat Rev Immunol. 2020 Oct;20(10):633-643. doi: 10.1038/s41577-020-00410-0. Epub 2020 Aug 11. Nat Rev Immunol. 2020. PMID: 32782358 Free PMC article. Review.
-
Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective.Cytometry A. 2020 Jul;97(7):662-667. doi: 10.1002/cyto.a.24047. Epub 2020 Jun 7. Cytometry A. 2020. PMID: 32506725 Free PMC article. Review.
Cited by
-
From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2.Vaccines (Basel). 2024 Apr 25;12(5):459. doi: 10.3390/vaccines12050459. Vaccines (Basel). 2024. PMID: 38793710 Free PMC article. Review.
-
The "original antigenic sin" and its relevance for SARS-CoV-2 (COVID-19) vaccination.Clin Immunol Commun. 2021 Dec;1:13-16. doi: 10.1016/j.clicom.2021.10.001. Epub 2021 Oct 8. Clin Immunol Commun. 2021. PMID: 38620690 Free PMC article. Review.
-
Enhancement of SARS-CoV-2 Infection via Crosslinking of Adjacent Spike Proteins by N-Terminal Domain-Targeting Antibodies.Viruses. 2023 Dec 13;15(12):2421. doi: 10.3390/v15122421. Viruses. 2023. PMID: 38140662 Free PMC article.
-
Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants.Virol J. 2023 Dec 1;20(1):285. doi: 10.1186/s12985-023-02230-9. Virol J. 2023. PMID: 38041113 Free PMC article.
-
Gag Virus-like Particles Functionalized with SARS-CoV-2 Variants: Generation, Characterization and Recognition by COVID-19 Convalescent Patients' Sera.Vaccines (Basel). 2023 Oct 26;11(11):1641. doi: 10.3390/vaccines11111641. Vaccines (Basel). 2023. PMID: 38005972 Free PMC article.
References
-
- Brennan K., Bowie A. G. 2010. Activation of host pattern recognition receptors by viruses. Curr. Opin. Microbiol. 13: 503–507 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous